Overview

Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat

Status:
Withdrawn
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to learn about the effect of Liraglutide (Victoza) on the fat of the heart and some fat cells in blood.
Phase:
Phase 4
Details
Lead Sponsor:
University of Miami
Treatments:
Glucagon-Like Peptide 1
Liraglutide